amphetamine has been researched along with Anhedonia in 8 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Anhedonia: Inability to experience pleasure due to impairment or dysfunction of normal psychological and neurobiological mechanisms. It is a symptom of many PSYCHOTIC DISORDERS (e.g., DEPRESSIVE DISORDER, MAJOR; and SCHIZOPHRENIA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Asenapine is indicated for the treatment of schizophrenia and manic episodes in bipolar disorder (BPD)." | 3.81 | The effects of the atypical antipsychotic asenapine in a strain-specific battery of tests for mania-like behaviors. ( Einat, H; Ene, HM; Kara, NZ, 2015) |
| "These findings may direct future treatment of anhedonia by targeting DA and glucocorticoid systems, as well as a possible interaction between the two." | 1.48 | Investigating dopamine and glucocorticoid systems as underlying mechanisms of anhedonia. ( Lamontagne, SJ; Melendez, SI; Olmstead, MC, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Kangas, BD | 1 |
| Wooldridge, LM | 1 |
| Luc, OT | 1 |
| Bergman, J | 1 |
| Pizzagalli, DA | 1 |
| Spierling, SR | 1 |
| Mattock, M | 1 |
| Zorrilla, EP | 1 |
| Pappas, AL | 1 |
| Bey, AL | 1 |
| Wang, X | 1 |
| Rossi, M | 1 |
| Kim, YH | 1 |
| Yan, H | 1 |
| Porkka, F | 1 |
| Duffney, LJ | 1 |
| Phillips, SM | 1 |
| Cao, X | 1 |
| Ding, JD | 1 |
| Rodriguiz, RM | 1 |
| Yin, HH | 1 |
| Weinberg, RJ | 1 |
| Ji, RR | 1 |
| Wetsel, WC | 1 |
| Jiang, YH | 1 |
| Lamontagne, SJ | 1 |
| Melendez, SI | 1 |
| Olmstead, MC | 1 |
| Giovanoli, S | 1 |
| Werge, TM | 1 |
| Mortensen, PB | 1 |
| Didriksen, M | 1 |
| Meyer, U | 1 |
| Felger, JC | 1 |
| Mun, J | 1 |
| Kimmel, HL | 1 |
| Nye, JA | 1 |
| Drake, DF | 1 |
| Hernandez, CR | 1 |
| Freeman, AA | 1 |
| Rye, DB | 1 |
| Goodman, MM | 1 |
| Howell, LL | 1 |
| Miller, AH | 1 |
| Ene, HM | 1 |
| Kara, NZ | 1 |
| Einat, H | 1 |
| Miczek, KA | 1 |
| Nikulina, EM | 1 |
| Takahashi, A | 1 |
| Covington, HE | 1 |
| Yap, JJ | 1 |
| Boyson, CO | 1 |
| Shimamoto, A | 1 |
| de Almeida, RM | 1 |
1 review available for amphetamine and Anhedonia
| Article | Year |
|---|---|
Gene expression in aminergic and peptidergic cells during aggression and defeat: relevance to violence, depression and drug abuse.
Topics: Aggression; Amines; Amphetamine; Anhedonia; Animals; Brain; Brain Stem; Cocaine; Female; Gene Expres | 2011 |
7 other studies available for amphetamine and Anhedonia
| Article | Year |
|---|---|
Empirical validation of a touchscreen probabilistic reward task in rats.
Topics: Amphetamine; Anhedonia; Animals; Depressive Disorder, Major; Female; Learning; Rats; Reward | 2020 |
Modeling hypohedonia following repeated social defeat: Individual vulnerability and dopaminergic involvement.
Topics: Amphetamine; Anhedonia; Animals; Choice Behavior; Dominance-Subordination; Dopamine; Dopamine Uptake | 2017 |
Deficiency of Shank2 causes mania-like behavior that responds to mood stabilizers.
Topics: Amphetamine; Anhedonia; Animals; Antimanic Agents; Behavior, Animal; Bipolar Disorder; Central Nervo | 2017 |
Investigating dopamine and glucocorticoid systems as underlying mechanisms of anhedonia.
Topics: Amphetamine; Anhedonia; Animals; Dopamine; Dopamine Agents; Dopamine Agonists; Glucocorticoids; Lear | 2018 |
Interactive effects between hemizygous 15q13.3 microdeletion and peripubertal stress on adult behavioral functions.
Topics: Age Factors; Amphetamine; Anhedonia; Animals; Anxiety; Behavior, Animal; Central Nervous System Stim | 2019 |
Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.
Topics: Amphetamine; Anhedonia; Animals; Carbon Radioisotopes; Corpus Striatum; Dopamine; Dopamine Antagonis | 2013 |
The effects of the atypical antipsychotic asenapine in a strain-specific battery of tests for mania-like behaviors.
Topics: Akathisia, Drug-Induced; Amphetamine; Anhedonia; Animals; Antimanic Agents; Antipsychotic Agents; Ap | 2015 |